摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-trifluoromethyl-3-methylquinoxaline-2-carboxaldehyde-1,4-di-N-oxide | 62018-41-1

中文名称
——
中文别名
——
英文名称
7-trifluoromethyl-3-methylquinoxaline-2-carboxaldehyde-1,4-di-N-oxide
英文别名
2-Formyl-3-methyl-1-oxo-7-(trifluoromethyl)quinoxalin-1-ium-4(1H)-olate;3-methyl-4-oxido-1-oxo-7-(trifluoromethyl)quinoxalin-1-ium-2-carbaldehyde
7-trifluoromethyl-3-methylquinoxaline-2-carboxaldehyde-1,4-di-N-oxide化学式
CAS
62018-41-1
化学式
C11H7F3N2O3
mdl
——
分子量
272.183
InChiKey
YSPQAOMXSKAVMB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    457.4±55.0 °C(Predicted)
  • 密度:
    1.51±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    19
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    63.4
  • 氢给体数:
    0
  • 氢受体数:
    7

SDS

SDS:0ba2d2cd44b40db5b14676dedd37368b
查看

反应信息

  • 作为反应物:
    描述:
    异烟肼7-trifluoromethyl-3-methylquinoxaline-2-carboxaldehyde-1,4-di-N-oxide 在 sodium metabisulfite 作用下, 以 四氢呋喃 为溶剂, 生成 7-trifluoromethyl-3-methyl-1,4-dioxy-quinoxaline-2-ylmethylene hydrazide isonicotinic acid
    参考文献:
    名称:
    New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents
    摘要:
    The increase in the prevalence of drug-resistant tuberculosis cases demonstrates the need of discovering new and promising compounds with antimycobacterial activity. As a continuation of our research and with the aim of identifying new antitubercular drugs candidates, a new series of quinoxaline 1,4-di-N-oxide derivatives containing isoniazid was synthesized and evaluated for in vitro anti-tuberculosis activity against Mycobacterium tuberculosis H37Rv strain. Moreover, various drug-like properties of new compounds were predicted. Taking into account the biological results and the promising drug-likeness profile of these compounds, make them valid leads for further experimental research. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.04.072
  • 作为产物:
    参考文献:
    名称:
    New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents
    摘要:
    The increase in the prevalence of drug-resistant tuberculosis cases demonstrates the need of discovering new and promising compounds with antimycobacterial activity. As a continuation of our research and with the aim of identifying new antitubercular drugs candidates, a new series of quinoxaline 1,4-di-N-oxide derivatives containing isoniazid was synthesized and evaluated for in vitro anti-tuberculosis activity against Mycobacterium tuberculosis H37Rv strain. Moreover, various drug-like properties of new compounds were predicted. Taking into account the biological results and the promising drug-likeness profile of these compounds, make them valid leads for further experimental research. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.04.072
点击查看最新优质反应信息

文献信息

  • New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents
    作者:Enrique Torres、Elsa Moreno、Saioa Ancizu、Carlos Barea、Silvia Galiano、Ignacio Aldana、Antonio Monge、Silvia Pérez-Silanes
    DOI:10.1016/j.bmcl.2011.04.072
    日期:2011.6
    The increase in the prevalence of drug-resistant tuberculosis cases demonstrates the need of discovering new and promising compounds with antimycobacterial activity. As a continuation of our research and with the aim of identifying new antitubercular drugs candidates, a new series of quinoxaline 1,4-di-N-oxide derivatives containing isoniazid was synthesized and evaluated for in vitro anti-tuberculosis activity against Mycobacterium tuberculosis H37Rv strain. Moreover, various drug-like properties of new compounds were predicted. Taking into account the biological results and the promising drug-likeness profile of these compounds, make them valid leads for further experimental research. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多